Study shows ctDNA positivity is the most prognostic factor, demonstrating the potential for Signatera to redefine adjuvant treatment pathways in endometrial cancer This real-world study analyzed 267 ...
Cancer is caused by changes in DNA that lead to uncontrolled cell growth. Some of these changes correspond to inherited or germline mutations; most correspond to acquired or sporadic mutations. Cancer ...
Overall pan-cancer sensitivity of 94% and specificity of 100%, with analytical detection down to 1 PPM AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback